Literature DB >> 21995987

Cosmetic improvement of nevus of Ota by scleral allograft overlay.

Bum-Joo Cho1, Ji-Won Kwon, Young Keun Han, Joo Hak Kim, Won Ryang Wee, Jin Hak Lee.   

Abstract

OBJECTIVE: To report surgical outcome of a new therapeutic technique for nevus of Ota by scleral allograft overlay.
DESIGN: Noncomparative clinical interventional study. PARTICIPANTS: Eight eyes of 7 patients with scleral nevus of Ota.
METHODS: Patients underwent subconjunctival scleral allograft overlay between September 2005 and June 2007 at Seoul National University Hospital. Preoperative neval extent, postoperative cosmesis, complications, and visual acuity change were evaluated.
RESULTS: Most of the patients showed satisfying cosmetic improvement. There were no significant complications in a follow-up period of more than 3 years.
CONCLUSIONS: Scleral allograft overlay is a safe and effective procedure for cosmetic improvement of nevus of Ota.
Copyright © 2011 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21995987     DOI: 10.1016/j.jcjo.2011.07.006

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  3 in total

1.  [Results of Cutler-Beard procedure for reconstruction of extensive full thickness upper eyelid defects following tumor resection].

Authors:  A Kopecky; K R Koch; F Bucher; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2016-04       Impact factor: 1.059

2.  Utility of anterior segment optical coherence tomography in the surgical planning of superficial sclerectomy in oculodermal melanocytosis (nevus of Ota): A case report and review of literature.

Authors:  Alessandro Mularoni; Laura Rania; Matteo Forlini; Eleonora Benedetta Marcheggiani; Aurelio Imburgia
Journal:  Am J Ophthalmol Case Rep       Date:  2021-07-23

3.  Use of an Autologous Lamellar Scleral Graft to Repair a Scleral Melt After Mitomycin Application.

Authors:  Nihat Polat
Journal:  Ophthalmol Ther       Date:  2014-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.